Drug Shortage Report for TIMOPTIC-XE

Last updated on 2020-06-19 History
Report ID 103337
Drug Identification Number 02171899
Brand name TIMOPTIC-XE
Common or Proper name Timoptic XE
Company Name PURDUE PHARMA
Market Status MARKETED
Active Ingredient(s) TIMOLOL
Strength(s) 0.5%
Dosage form(s) SOLUTION (EXTENDED RELEASE)
Route of administration OPHTHALMIC
Packaging size 5ml
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-01-22
Actual start date 2020-01-17
Estimated end date 2020-06-29
Actual end date 2020-06-18
Shortage status Resolved
Updated date 2020-06-19
Company comments
Health Canada comments
Contact Address 575 GRANITE COURT
PICKERING, ONTARIO
CANADA L1W 3W8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2020-06-19 English Compare
v16 2020-06-18 French Compare
v15 2020-06-18 English Compare
v14 2020-05-19 French Compare
v13 2020-05-19 English Compare
v12 2020-04-07 French Compare
v11 2020-04-07 English Compare
v10 2020-04-07 French Compare
v9 2020-04-07 English Compare
v8 2020-03-24 French Compare
v7 2020-03-24 English Compare
v6 2020-01-23 English Compare
v5 2020-01-15 French Compare
v4 2020-01-15 English Compare
v3 2020-01-15 French Compare
v2 2020-01-15 English Compare
v1 2020-01-15 English Compare